EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Cyclosporin treatment of anal and perianal lesions associated with Crohn’s disease

Hüseyin ÇAT ¹ , Iradj SOPHANI ¹ , Mare LEMANN ² , Robert MODIGLANI ¹ , J. Claude SOLUE ¹

Author Affiliation(s)

1.

Centre Hospitalo Universitaire Claude Bernard-Bichat Service de gastro-enterologie, Paris

2.

Centre Hospitalo Universitaire Saint Louis Service de gastro-enterologie Paris

Turk J Gastroenterol 2003; 14: 121-127

Keywords : Crohn’s disease, cyclosporin-A, anal-perianal lesion.

Read: 1976 Downloads: 1746 Published: 25 July 2019

Volume 14, Issue 2, June 2003

Previous Article

Files